UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?

BMC musculoskeletal disorders, 2020-04, Vol.21 (1), p.209-209, Article 209

2020

Volltextzugriff (PDF)

P002 Implementation of a new digital exercise tool in axial spondyloarthritis and a musculoskeletal therapy outpatient department: a service evaluation

Rheumatology (Oxford, England), 2023-04, Vol.62 (Supplement_2)

2023

Volltextzugriff (PDF)

Ustekinumab for resistant psoriatic arthritis

Journal of rheumatology, 2013-02, Vol.40 (2), p.207-207

2013

Volltextzugriff (PDF)

Recognition of Preclinical and Early Disease in Axial Spondyloarthritis

Rheumatic diseases clinics of North America, 2014-11, Vol.40 (4), p.685-697

2014

Volltextzugriff (PDF)

Infection risk and biologics: current update

Current opinion in rheumatology, 2014-07, Vol.26 (4), p.404-409

Wallis, Dinny

2014

Volltextzugriff (PDF)

The ClASsification for Psoriatic ARthritis (CASPAR) Criteria – A Retrospective Feasibility, Sensitivity, and Specificity Study: Table 1

Journal of rheumatology, 2012-01, Vol.39 (1), p.154-156

2012

Volltextzugriff (PDF)

The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study

Journal of rheumatology, 2012-01, Vol.39 (1), p.154

2012

Volltextzugriff (PDF)

Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?

Journal of rheumatology, 2013-12, Vol.40 (12), p.2038-2041

2013

Volltextzugriff (PDF)

267 Improving standards of care of axial spondyloarthritis through implementation of NICE Quality standards 170 across the South Coast Axial Spondyloarthritis Network

Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)

2019

Volltextzugriff (PDF)

P051 Symptoms of COVID-19 and anxiety levels in adult patients receiving b-and ts-DMARDS using an online reporting system

Rheumatology (Oxford, England), 2021-04, Vol.60 (Supplement_1)

2021

Volltextzugriff (PDF)

Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study

Arthritis research & therapy, 2013-10, Vol.15 (5), p.R166-R166

2013

Volltextzugriff (PDF)

270 Tapering biological therapies: what do patients think?

Rheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3)

2018

Volltextzugriff (PDF)

Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort

Rheumatology (Oxford, England), 2015-01, Vol.54 (1), p.152-156

2015

Volltextzugriff (PDF)

Clinical Efficacy of Celecoxib Compared to Acetaminophen in Chronic Nonspecific Low Back Pain: Results of a Randomized Controlled Trial

Arthritis care & research (2010), 2016-06, Vol.68 (6), p.845-852

2016

Volltextzugriff (PDF)

024An Unusual Case of Neck Pain: Calcium Pyrophosphate Deposition Disease of the Atlanto-Axial Joint

Rheumatology (Oxford, England), 2016-04, Vol.55 (suppl_1), p.i71-i71

2016

Volltextzugriff (PDF)

E60Biologic Dose Reduction in Rheumatoid Arthritis: What do Patients Think? Results from a Patient and Public Involvement Event

Rheumatology (Oxford, England), 2016-04, Vol.55 (suppl_1), p.i187-i187

2016

Volltextzugriff (PDF)

100. HIGH LEVELS OF EMPLOYMENT BUT PERSISTING WORK IMPAIRMENT IN PATIENTS WITH SEVERE AXIAL SPONDYLOARTHRITIS USING BIOLOGIC THERAPIES

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_2)

2017

Volltextzugriff (PDF)

Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis

Rheumatology (Oxford, England), 2013-02, Vol.52 (2), p.261-266

2013

Volltextzugriff (PDF)

Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?

Rheumatology advances in practice, 2020-07, Vol.4 (2), p.rkaa061-rkaa061

2020

Volltextzugriff (PDF)

Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis

Rheumatology advances in practice, 2018-01, Vol.2 (1), p.rky001

2018

Volltextzugriff (PDF)

Anti-Golgi autoantibodies: prevalence and disease associations in a rheumatic disease population

International journal of rheumatic diseases, 2012-04, Vol.15 (2), p.e23-e25

2012

Volltextzugriff (PDF)

Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis

Rheumatology advances in practice, 2018, Vol.2 (1), p.rky001-rky001

2018

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)
Berichte
(1)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Rheumatology
(13)
Science & Technology
(13)
Humans
(11)
Adult
(8)
Female
(8)
Male
(8)
Ankylosing Spondylitis
(6)
Middle Aged
(6)
Cohort Studies
(4)
Antirheumatic Agents - Therapeutic Use
(3)
Axial Spondyloarthritis
(3)
Diagnosis
(3)
Adolescent
(2)
Arthritis
(2)
Back Pain
(2)
Biological And Medical Sciences
(2)
Biological Products - Therapeutic Use
(2)
Care And Treatment
(2)
Clinical Trials
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?

P002 Implementation of a new digital exercise tool in axial spondyloarthritis and a musculoskeletal therapy outpatient department: a service evaluation

Ustekinumab for resistant psoriatic arthritis

Recognition of Preclinical and Early Disease in Axial Spondyloarthritis

Infection risk and biologics: current update

The ClASsification for Psoriatic ARthritis (CASPAR) Criteria – A Retrospective Feasibility, Sensitivity, and Specificity Study: Table 1

The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study

Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?

267 Improving standards of care of axial spondyloarthritis through implementation of NICE Quality standards 170 across the South Coast Axial Spondyloarthritis Network

P051 Symptoms of COVID-19 and anxiety levels in adult patients receiving b-and ts-DMARDS using an online reporting system

Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study

270 Tapering biological therapies: what do patients think?

Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort

Clinical Efficacy of Celecoxib Compared to Acetaminophen in Chronic Nonspecific Low Back Pain: Results of a Randomized Controlled Trial

024An Unusual Case of Neck Pain: Calcium Pyrophosphate Deposition Disease of the Atlanto-Axial Joint

E60Biologic Dose Reduction in Rheumatoid Arthritis: What do Patients Think? Results from a Patient and Public Involvement Event

100. HIGH LEVELS OF EMPLOYMENT BUT PERSISTING WORK IMPAIRMENT IN PATIENTS WITH SEVERE AXIAL SPONDYLOARTHRITIS USING BIOLOGIC THERAPIES

Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis

Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?

Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis

Anti-Golgi autoantibodies: prevalence and disease associations in a rheumatic disease population

Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis

Suchergebnisse filtern